| 1. |
In the United States, AIDS = 28 old illnesses and one non-illness: |
|
|
|
1983 original AIDS definition (12 illnesses): Pneumocystis carinii
pneumonia, Kaposi's sarcoma, toxoplasmosis, strongyloidosis,
aspergillosis, cryptococcosis, candidiasis, cryptosporidiosis,
cytomegalovirus, herpes simplex, progressive multifocal
leukoencephalopathy, lymphoma of the brain
|
|
|
|
1985 revised definition (seven more old illnesses added):
Mycobacterium avium complex, histoplasmosis, isosporiasis, Burkitt's
lymphoma, immunoblastic lymphoma, candidiasis of the bronchi,
trachea and lungs, and a positive HIV antibody test.
|
|
|
|
1987 revised definition (six additional illnesses): Encephalopathy,
Mycobacterium tuberculosis, wasting syndrome, coccidioidomycosis,
cytomegalovirus retinitis, Salmonella septicemia. HIV antibody test
no longer required.
|
|
|
|
1993 revised definition (three more illnesses plus one surrogate
marker): Recurrent bacterial pneumonia, invasive cervical cancer,
pulmonary tuberculosis, T Cell count of <200 or <14% of total
lymphocytes (non-illness).
|
|
|
|
Source: Duesberg P, Yiamouyannis J, 1995 AIDS: The Good News Is
HIV Doesn't Cause It Health Action Press
|
|
|
| 2. |
US Centers for Disease Control 1994 HIV/AIDS Surveillance Report
Year-end edition 1993 |
|
|
| 3. |
Navarro M AIDS Definition Widened to Include Blood Cell Count
August 8 1993 New York Times; Altman L AIDS Cases Increase Among
Heterosexuals March 11 1994 New York Times |
|
|
| 4. |
US Centers for Disease Control HIV/AIDS Surveillance Report
Year-end editions 1998, 1997, 1996, 1995, 1994, 1993 |
|
|
| 5. |
US Centers for Disease Control 1998 HIV/AIDS Surveillance Report
Year-end edition 1997 Table11 p17 |
|
|
| 6. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end edition 1998 p43 |
|
|
| 7. |
Duesberg P 1993 The HIV Gap in National Statistics Bio/Technology
11:955-6 |
|
|
| 8. |
Laboratory Centre for Disease Control, Health Canada, 1998 HIV and
AIDS in Canada: Surveillance Report to December 31, 1997; US Centers
for Disease Control 1999 HIV/AIDS Surveillance Report Year-end 1998 |
|
|
| 9. |
US Centers for Disease Control 1998 HIV/AIDS Surveillance Report
Year-end edition 1997 Figure 6 p25; US Centers for Disease Control
1999 HIV/AIDS Surveillance Report Year-end edition 1998 |
|
|
| 10. |
World Health Organization 1985 Bangui definition for AIDS in
Africa (current use confirmed by WHO April 1999); WHO case
definitions for AIDS surveillance in adults and adolescents, Weekly
Epidemiological Record September 1994; 69:273-80 (current use
confirmed by WHO April 1999) |
|
|
| 11. |
Duesberg P 1996 Inventing the AIDS Virus: Regnery Press,
Washington DC p141-145 |
|
|
| 12. |
Duesberg P 1996 Inventing the AIDS Virus: Regnery Press,
Washington DC p54-58 |
|
|
| 13. |
Carins J 1978 Cancer: Science and Society WH Freeman and Company,
San Francisco |
|
|
| 14. |
Duesberg P, Rasnick D 1998 The AIDS Dilemma: Drug Diseases Blamed
on a Passenger Virus Genetica 104:85-132; Mullis K 1998 Dancing
Naked in the Mindfield Pantheon Books, New York p171-190; Shenton J
1998 Positively False St Martin's Press, New York p6-17 |
|
|
| 15. |
Mullis K 1988 Dancing Naked in the Mindfield Pantheon Books, New
York p 178; Duesberg P 1996 Inventing the AIDS Virus Regnery Press,
Washington DC p 89-96 |
|
|
| 16. |
Altman L New York Times, April 23 1984 |
|
|
| 17. |
Altman L Researchers Believe AIDS Virus is Found New York Times,
April 24 1984 (Dr. James Curran, head of the CDC's AIDS
investigating team, calls discovery "the virus that causes
AIDS") |
|
|
| 18. |
Gallo found HIV in only 26 of 63 AIDS patients (41%) Source: Gallo
R May 4 1984 Science Volume 224 p502 |
|
|
| 19. |
In 1983, Montagnier sent Gallo "retrovirus particles" (LAV)
taken from the lymph node of a male homosexual without AIDS. Source:
Science May 20 1983, Vol 220; the virus Gallo claimed to have
discovered in 1984 was found to actually be Montagnier's LAV.
Source: New Scientist, February 12 1987 |
|
|
| 20. |
Dingell J Misconduct in Medical Research, New England Journal of
Medicine 1993 328:1610-1615; Co-Discoverer of HIV Loses Bid to
Regain Job AIDS Policy and Law May 14 1999 Vol 14 No 9; Crewdson J
In Gallo Case, Truth Termed a Casualty: Science Subverted in AIDS
Research Chicago Tribune, January 1 1995 |
|
|
| 21. |
Baffour A Are 26 Million Africans Dying of AIDS? December 1998 New
African Magazine p34-42 |
|
|
| 22. |
Duesberg P Inventing the AIDS Virus Regnery Press, Washington DC;
Root-Bernstein R 1993 Rethinking AIDS The Free Press, New York |
|
|
| 23. |
Cordes R, et al 1995 Pitfalls in HIV Testing Postgraduate Medicine
98:177; Langedijk J, et al 1992 Identification of Cross-reaction
Epitopes Recognized by HIV-1 False-positive Sera AIDS 6:1547-1548;
Strandstrom H, et al 1990 Studies with Canine Sera that Contain
Antibodies which Recognize HIV Structural Proteins Cancer Research,
September 1:50(17 Suppl):56285-56305; Germanson T 1989 Screening for
HIV: Can We Afford the Confusion of the False Positive Rate? Journal
of Clinical Epidemiology 42:1235; Weiss R, et al 1988 HIV Testing is
the Answer-What's the Question? New England Journal of Medicine
319:1010-1012; Burke, et al 1988 Measurement of the False Positive
Rate in a Screening Program for HIV Infections New England Journal
of Medicine 319(15):961-964; US News and World Report, November 23
1987 p22c; Jackson G, et al 1988 Passive Immunoneutralisation of
Human Immuno-deficiency Virus in Patients with Advanced AIDS Lancet,
September 17:647 |
|
|
| 24. |
Papadopulos-Eleopulos E, et al 1993 Is a Positive Western Blot
Proof of HIV Infection? Bio/Technology Journal Vol 11 p696-707 |
|
|
| 25. |
Papadopulos-Eleopulos E, et al 1993 Has Gallo Proven the Role of
HIV in AIDS? Emergency Medicine 5:113-123 |
|
|
| 26. |
Papadopulos-Eleopulous E, et al 1993 Is a Positive Western Blot
Proof of HIV Infection? Bio/Technology Vol. 11 |
|
|
| 27. |
Strandstrom H, et al 1990 Studies with Canine Sera which Recognise
HIV Structural Proteins, Cancer Research 50:5628s-5630s. Source:
Testing, Testing, 1,2,3... Turner V 1996 Contiuum Vol 3:5 p8-11 |
|
|
| 28. |
Papadopolus-Eleopulos E, et al 1993 Is a Positive Western Blot
Proof of HIV Infection? Bio/Technology Journal Vol 11 p696-701;
Quantum Clinical Laboratory, Los Angeles, CA: HIV antibody test
results for Christine Maggiore April 9 1992 HIV reactive, WB
positive positive; March 27 1993 HIV reactive, WB indeterminate;
September 1 1993 HIV non-reactive |
|
|
| 29. |
Abbott Laboratory's ELISA HIV antibody test kit pamphlet |
|
|
| 30. |
Continuum Vol 3:4 with thanks to Val Turner, Royal Perth Hospital,
Australia; Bio/Technology June 1993 11:696-707 |
|
|
| 31. |
Roche Amplicor PCR Diagnostics HIV-1 Monitor test kit pamphlet |
|
|
| 33. |
Curran J 1985 The Epidemiology of AIDS: Current Status and Future
Prospects Science 229:1352-1357; Karon, et al 1996 Prevalence of HIV
Infections in the US Journal of the American Medical Association
276:126-131; Krieger L One in 300 US Adults Infected, San Francisco
Examiner July 7 1996 pA82 |
|
|
| 34. |
NBC Nightly News, March 10 1995: Robert Hager of NBC reported that
the CDC was about to lower estimates they knew were too high. CDC
spokesperson Michelle Bond remarked that the CDC officials were
reluctant to report lower numbers for fear of adverse budgetary
consequences. |
|
|
| 35. |
All STDs except genital herpes: US Centers for Disease Control
1997, Table 1: Cases of STDs reported by state health departments in
US 1941-1997, STD Surveillance p65-66. Genital herpes: Meyer T March
24 1998 Associated Press, Atlanta (Meyer quotes CDC and Dr. Charles
Bell of Texas Department of Health) |
|
|
| 36. |
US Centers for Disease Control 2003 HIV/AIDS Surveillance Report
Year-end edition 2002 (Deaths in persons with AIDS, cumulative
totals through December 2002) |
|
|
| 37. |
US Centers for Disease Control HIV/AIDS Surveillance Report
Year-end edition states "Reported deaths are not necessarily
caused by HIV-related disease" |
|
|
| 38. |
CDC Wonder website; The New York Times, death count, all ages, all
races, both genders 1981-2002 |
|
|
| 39. |
Lazarou J, et al 1998 Incidence of Adverse Drug Reactions in
Hospitalized Patients (1966-1996) Journal of the American Medical
Association, 279:1200; Manmaney T Medications Kill 100,000 Annually
Los Angeles Times April 15 1998; CDC Wonder website 2004 |
|
|
| 40. |
PBS 1998 The American Experience: Influenza 1918 |
|
|
| 41. |
World Health Organization Weekly Epidemiological Record November
2001 (current) |
|
|
| 42. |
UNAIDS June 1998 Report on the Global Epidemic; World Health
Organization June 1998, Weekly Epidemiological Record |
|
|
| 43. |
CDC National Vital Statistics Report October 7 1998, Vol 47:4
Table E p7 (Deaths and death rates, final 1996 and preliminary 1997) |
|
|
| 44. |
Geshekter C 1997 AIDS: The Leading Cause of Unjustified Hysteria,
Reappraising AIDS, February Vol 5:2 |
|
|
| 45. |
Institute of Medicine (IOM) 1996 Scientific Opportunities and
Public Needs; Webster K Disproportionate Funding Associated Press
June 16 1999 |
|
|
| 46. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end edition 1998 |
|
|
| 47. |
Crowne D, et al 1964 The Approval Motive John Wiley and Sons, New
York; Saxe L 1991 Lying: Thoughts of an Applied Social Psychologist
American Psychologist 46:409-415; Source: Brody S Sex at Risk
Transaction Publishers, New Brunswick |
|
|
| 48. |
Brody, S 1997 Sex at Risk Transaction Publishers, New Brunswick;
80%: Potterat, et al 1987 JAMA 256 p 12; 65%: Renzullo, et al 1990
JAIDS 3, p266-271; 83%-90%: Committee on AIDS Research and the
Behavioral, Social, and Statistical Sciences 1989; 69%: Chicago Dept
of Public Health, Journal of AIDS 1997; 99.4%: NYC Dept of Health,
American Journal of Epidemiology 137:2 |
|
|
| 49. |
Figures for AIDS by Risk Groups are based on cumulative figures
through 1998 and do not include cases where risk status was not
assessed; AIDS by Health Status are for years 1993 through 1997
using Table 11 of the 93-97 US CDC HIV/AIDS Surveillance Reports
(1997 was the last year the CDC published the data in Table 11);
AIDS by Gender is based on cumulative figures through 1998 |
|
|
| 50. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end 1998 |
|
|
| 51. |
Burke D, et al 1990 Seroprevalence Among Applicants for US
Military Service Unpublished data through 1997 from US Military
Processing: For a copy of this unpublished data, send a SASE to the
author |
|
|
| 52. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end 1998 p26 |
|
|
| 53. |
Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington
DC p183 |
|
|
| 54. |
Holding R, Carlsen W 1998 Epidemic Ravages Caregivers San
Francisco Chronicle p1, A6-A8 |
|
|
| 55. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end 1998 Table 7 p14; US Centers for Disease Control 1998
HIV/AIDS Surveillance Report Year-end 1997 Table 8 p15 |
|
|
| 56. |
Laboratory Centre for Disease Control, Health Canada, April 1998
Gonorrhea in Canada; US Centers for Disease Control 1998 HIV/AIDS
Surveillance Report Year-end 1997, Tables 13A and 13B; Interview
with LCDC Bureau of AIDS and STDs Office of Don Sutherland,
September 14, 1998: Gonorrhea cases in Canada |
|
|
| 57. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end 1998 Table 7 p14; US Centers for Disease Control 1998
HIV/AIDS Surveillance Report Year-end 1997 Table 8 p15 |
|
|
| 58. |
Mok, et al 1987 Infants born to Mothers Seropositive for HIV
Lancet 1164-1168; European Collaborative Study 1991 Children Born to
Women with HIV 1 Lancet 337:253-260 |
|
|
| 59. |
Source: National Center for Health Statistics July 1996
703/821-8955: Cumulative SIDS deaths in children under 1 year of age
1983-1996, 1997 preliminary, 1981-1982 computed by average of years
1983-1993 |
|
|
| 60. |
Transactions of the Society of Actuaries, Vol XLIV p333-97; Boffey
P April 22 1988, Researchers List Odds of Getting AIDS in
Heterosexual Intercourse New York Times; Hearst N, Hulley S April
1988 Journal of the American Medical Association; Dangers Real and
Imagined December 8 1997 Wall Street Journal; Discover magazine, May
1996 p82 |
|
|
| 61. |
World Health Organization, November 1998 Weekly Epidemiological
Record (current) |
|
|
| 62. |
Harvard University Global Burden of Disease Study, 1996; World
Health Organization, Geneva 1996 Fighting Disease, Fostering
Development; Geshekter C Rethinking AIDS in Africa Reappraising AIDS
Vol 3:2 February 1995 |
|
|
| 63. |
World Health Organization 1985 Bangui definition for AIDS in
Africa (in current use); WHO case definitions for AIDS surveillance
in adults and adolescents Weekly Epidemiological Record September
1994 69:273-80 (confirmed April 1999 by WHO) |
|
|
| 64. |
World Health Organization, November 1998 Weekly Epidemiological
Record (current); Harvard University Global Burden of Disease Study,
1996; World Health Organization, Geneva 1996 Fighting Disease,
Fostering Development; Geshekter C Rethinking AIDS in Africa
Reappraising AIDS Vol 3:2 February 1995; World Health Organization
1985 Bangui definition for AIDS in Africa (in current use); WHO case
definitions for AIDS surveillance in adults and adolescents Weekly
Epidemiological Record September 1994 69:273-80 (confirmed April
1999 by WHO); World Health Organization World Health Report 1998
Annual cases of selected diseases |
|
|
| 65. |
Kestler H, et al 1990 Induction of AIDS in Rhesus Monkey by
Molecularly Cloned SIV Science 2448:1109-112; Kestler, et al 1991
Importance of Net Gene for Maintenance of High Virus Loads Cell
65:651-662; Fultz, et al 1990 Humoral Response to SIV/SMM Infection
in Macaque and Mangabey Monkeys Journal of AIDS 3:319-329; Weiss R,
et al 1985 Molecular Biology of RNA Tumor Viruses Cold Spring Harbor
Press, New York; Blatner W, et al 1988 HIV Causes AIDS Science
241:514-515; Lambrou E 1994 AIDS Scare or Scam p14-15 Vantage Press,
New York |
|
|
| 66. |
Gao, et al Nature February 4 1999 |
|
|
| 67. |
World Health Organization, November 1998 Weekly Epidemiological
Record (current) |
|
|
| 68. |
Russell R Kenya Slow to Face Up to AIDS Scourge Reuters November
25 1998 |
|
|
| 69. |
World Health Organization World Health Report 1998 |
|
|
| 70. |
World Health Organization World Health Report 1998 Annual cases of
selected diseases |
|
|
| 71. |
Journal of AIDS 1994 7:8 p876 |
|
|
| 72. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end 1998; 9(2) Calculations: David Crowe, Alberta Reappraising
AIDS Society |
|
|
| 73. |
US Centers for Disease Control HIV/AIDS Surveillance Report
Year-end editions 1997, 1996, 1995, 1994, 1993 (AIDS indicator
conditions reported by age group, United States) |
|
|
| 74. |
US Centers for Disease Control 1998 HIV/AIDS Surveillance Report
Year-end 1997 p25 Figure 6 |
|
|
| 75. |
US Centers for Disease Control 1998 HIV/AIDS Surveillance Report
Year-end 1997 p25 Figure 6 |
|
|
| 76. |
POZ magazine July 1999: Glaxo-Wellcome Ad for Ziagen (abacavir
sulfate), December 1998 MG-001; Merck Ad for Crixivan (indinavir)
Merck and Co, Inc. 1998 99-4084; Roxanne Ad for Viramune (nevirapine)
July 1999, RX-2140 (4/98); Glaxo-Wellcome Ad for Combivir (lamivudine/zidovudine)
March 1999 |
|
|
| 77. |
POZ magazine July 1999: Glaxo-Wellcome Ad for Combivir |
|
|
| 78. |
Hammer S, et al 1997 A Controlled Trial of Two Nucleoside
Analogues Indinavir in Persons with HIV New England Journal of
Medicine 337:725-733 |
|
|
| 79. |
Merck Ad for Crixivan (indinavir) Merck and Co, Inc. 1998 99-4084 |
|
|
| 80. |
POZ magazine July 1999: Glaxo-Wellcome Ad for Ziagen (abacavir
sulfate), December 1998 MG-001; Merck Ad for Crixivan (indinavir)
Merck and Co, Inc. 1998 99-4084; Roxanne Ad for Viramune (nevirapine)
July 1999, RX-2140 (4/98); Glaxo-Wellcome Ad for Combivir (lamivudine/zidovudine),
March 1999; FDA Advisory (warning of spontaneous bleeding in 15
hemophiliacs using protease inhibitors), July 16 1996; Dube M,
Johnson D, et al 1997 Protease Inhibitor Associated Hyperglycemia
Lancet 350:713-4; Kotler D Truncal Obesity February 20 1998 Clinical
Care Options for HIV (Monthly Experts Column); Garrett L The Virus
at the End of the World Esquire March 1 1999; Lo J, et al 1998
Buffalo Hump in Men with HIV-1 Lancet March 21 1998 p867-870; Miller
KD, et al Visceral Abdominal Fat Accumulation Associated with Use of
Indinavir p871-875; Kim L FDA Approves Another Protease Inhibitor
The Atlanta Journal and Constitution April 17 1999 p2E; Mickleburgh
R, Study AIDS Drugs Long Term, Makers Told The Globe and Mail
(Canada) May 4 1999; Colebunders E, et al Sexual Dysfunction with
Protease Inhibitors Lancet 353 May 22 1999; Waldholz M, Tanouye E
Cocktail Break Wall Street Journal January 25 1999 |
|
|
| 81. |
James Curran on CNN, August 23 1998 8:00 pm EST |
|
|
| 82. |
Altman L New Cases Widen Views About AIDS New York Times January 5
1984 |
|
|
| 83. |
Auberbach, et al 1984, Am J Med 76:487; Boffey P AIDS in the
Future: Risk of Developing AIDS New York Times January 14 1986; JAMA
262: 3129-3130; Burkett E HIV: Not Guilty? Miami Herald December 23
1990 p12-17 |
|
|
| 84. |
Eckholm E Onset of AIDS After Transfusion Found to Lag Average of
5 Years, New York Times May 29 1986; Lambrou E 1994 AIDS: Scare or
Scam? Vantage Press, New York p15; Garrett L June 1999 Blacks May
Have Genetic Risk of HIV Infection, Alive & Kicking!; Waldholz
M, Tanouye E Cocktail Break Wall Street Journal January 25 1999 |
|
|
| 85. |
Johnson C, Philpott P Viral Load of Crap Reappraising AIDS Vol
4:10 October 1996; Duesberg P 1995 Nature 357 p197 |
|
|
| 86. |
Rasnick D Kinetics Analysis of Consecutive HIV Proteolytic
Cleavages of the Gag-Pol Polyprotein Journal of Biological Chemistry
March 7 1997 |
|
|
| 87. |
Mullis K October 1998 The Medical Establishment vs. The Truth
Penthouse Magazine |
|
|
| 88. |
Rich J, et al 1999 Misdiagnosis of HIV Infection by HIV-1 Plasma
Viral Load Testing: A Case Series Annals of Internal Medicine
130:37-39; Sullivan, et al Persistently Negative HIV-1 Antibody
Enzyme Immunoassay Screening Results for Patients with HIV-1
Infection and AIDS AIDS January 14 1999 13:89-96 |
|
|
| 89. |
Piatak M March 19 1993 High Levels of HIV-1 in Plasma During All
Stages of Infection Determined by Competitive PCR Science
259:1749-53; Roehr B Loading Zone POZ Magazine August 1999 p76 |
|
|
| 90. |
New England Journal of Medicine November 3 1994 331:18 p1176-1177 |
|
|
| 91. |
Semba R, et al 1993 Increased Mortality Associated with Vitamin A
Deficiency During HIV-1 Infection Arch Intern Med 153:2149-2154 |
|
|
| 92. |
WHO/UNAIDS, 1998 HIV and Infant Feeding: A Guide for Health Care
Managers and Supervisors FRH/Nut 98, 22 |
|
|
| 93. |
HealthNews Mothering magazine Summer 1997 p40; Dew J October 8
1999 Newborn HIV Tests Criticized New Haven Register |
|
|
| 94. |
Farber C AZT Roulette: The Impossible Choices Facing HIV Positive
Mothers Mothering magazine September/October 1998 Issue 90 |
|
|
| 95. |
Semba R, et al 1993 Increased Mortality Associated with Vitamin A
Deficiency During HIV-1 Infection Arch Intern Med 153:2149-2154 |
|
|
| 96. |
Kumar R, et al 1994 Zidovudine Use in Pregnancy: A Report on 104
cases and Birth Defects Journal of AIDS 7(10):1034-1039 |
|
|
| 97. |
Cordes R, et al 1995 Pitfalls in HIV Testing Postgraduate Medicine
98:177; Ng V, et al Serological Diagnosis with Recombinant
Peptides/Proteins Clinical Chemistry 37:1667-1668; Profitt M, et al
1993 Laboratory Diagnosis of HIV Infection Inf Dis Clin North Am
7:203; Steckelberg J, Cockerill F 1988 Serologic Testing for HIV
Antibodies Mayo Clinic Proc 63:373; Voevodi A 1992 HIV Screening in
Russia Lancet 339:1548 |
|
|
| 98. |
Mothering magazine Summer 1997 Health News p40 |
|
|
| 99. |
Cleary, et al 1987 Journal of the American Medical Association
258(13):1757-62 |
|
|
| 100. |
US Centers for Disease Control Recommendations of the US Public
Heath Service Task Force on the Use of Zidovudine [AZT] to Reduce
Perinatal Transmission of HIV Morbidity and Mortality Weekly Report
Vol 43 No RR-11 August 5 1994 |
|
|
| 101. |
Regush N No AZT For My Baby, Please ABCNews.com September 16 1999 |
|
|
| 102. |
Gwarteny D Baby's Risk for HIV Sparks Fight The Oregonian January
31 1999; Wright J Court Grants Delay in Baby HIV Case The
Register-Guard February 5 1999 |
|
|
| 103. |
Good Morning America September 9 1998 |
|
|
| 104. |
Philpott P Maine Mother Wins Court Fight Against HIV Doctors
Reappraising AIDS Vol 6 October 10 1998 |
|
|
| 105. |
Mother Wins Right to Stop HIV Drugs New York Times April 20 1999;
Dateline NBC January 25, 1999; A Mother's Instinct People Magazine
October 5 1998 p157-158 |
|
|
| 106. |
News Broadcast, CJOB 68 August 18 1999; PeritzI Mother Fights to
Block Son's HIV Drug Therapy The Globe and Mail (Canada) August 18
1999 |
|
|
| 107. |
McKittrick A Ethical Drug Pricing: An Oxymoron? Provincetown
Positive Spring 1999 p37-39 |
|
|
| 108. |
Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington
DC p 309-359 |
|
|
| 109. |
Physicians Desk Reference 1994 p32 |
|
|
| 110. |
Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington
DC p 309-359 |
|
|
| 111. |
Lauritsen J 1993 The AIDS War Askelpios, New York, FDA Documents
Show Fraud in AZT Trials p381-397 |
|
|
| 112. |
Lancet 1993 343:871, Concorde Coordinating Committee; Journal of
the American Medical Association 1988 203:3009; New England Journal
of Medicine 1992 326:437. Source: Hand T Why Antiviral Drugs Cannot
Resolve AIDS Reappraising AIDS Vol 4:9 September 1996 |
|
|
| 113. |
Source: Interview with Dr. Charles Thomas in video HIV=AIDS: Fact
or Fraud? Starvision Productions (Stephen Allen, prod.) Denver CO;
Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington
DC p 309-359 |
|
|
| 114. |
British Medical Journal July 15 1995 p156-158 (49%); Science
Magazine February 24 1995 p1080 (34%); JAMA 260:3009 1988; New
England Journal of Medicine 1992, 326:437. Source: Hand T Why
Antiviral Drugs Cannot Resolve AIDS Reappraising AIDS Vol 4:9
September 1996 |
|
|
| 115. |
Merck Manual 1992 16th edition p55, Merck Research Laboratories;
Glaxo-Wellcome information sheet accompanying Zidovudine |
|
|
| 116. |
Hammer S, et al 1997 A Controlled Trial of Two Nucleoside
Analogues Indinavir in Persons with HIV New England Journal of
Medicine 337:725-733 |
|
|
| 117. |
Merck ad for Crixivan A&U magazine July 1999 99-4084 910 (508)
CRX |
|
|
| 118. |
Anderson M The Big Tease Valley Advocate February 20 1997 |
|
|
| 119. |
Interview with Christine Maggiore September 1997 |
|
|
| 120. |
AIDS expert Dr. Bruce Walker on ABC News Nightline May 19 1999
11:35 PM EST |
|
|
| 121. |
Ostrom N The New York Native July 15 1996 Issue 691 |
|
|
| 122. |
POZ magazine July 1999: Glaxo-Wellcome Ad for Ziagen (abacavir
sulfate), December 1998 MG-001; Merck Ad for Crixivan (indinavir)
Merck and Co, Inc. 1998 99-4084; Roxanne Ad for Viramune (nevirapine)
July 1999, RX-2140 (4/98); Glaxo-Wellcome Ad for Combivir (lamivudine/zidovudine)
March 1999 |
|
|
| 123. |
Journal of the American Medical Association July 10 1996 |
|
|
| 124. |
Johnson H Rolling Stone Magazine Special Report: Dr. David Ho and
the Lazarus Equation March 6 1997 |
|
|
| 125. |
Levy J 1996 AIDS Surrogate Markers: Is There Truth in Numbers?
JAMA Vol 276 p161-162 |
|
|
| 126. |
Merck ad for Crixivan A&U magazine July 1999 99-4084 910 (508)
CRX |
|
|
| 127. |
Altman L New York Times February 2 1996; Garrett L Newsday March 5
1996; The Boston Globe February 1 1999 |
|
|
| 128. |
Dr. Raymond Schinazi of Emory University, Atlanta, Georgia.
Source: Garrett L Newsday March 31 1995 |
|
|
| 129. |
Lancet June 1 1997 Vol 349 p1745; Associated Press Report,
Philadelphia Inquirer June 13 1997; Anderson M The Big Tease The
Valley Advocate February 20 1997; Green F Cocktail Hangover
Cleveland Free Times May 5 1999 Vol 7 Issue 33; Signorile M 641,086
and Counting Out magazine September 1998 |
|
|
| 130. |
The Morning After POZ magazine February 1997 |
|
|
| 131. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end 1998; 9(2) Calculations: David Crowe, Alberta Reappraising
AIDS Society; US Centers for Disease Control 1998 HIV/AIDS
Surveillance Report Year-end 1997 p25 Figure 6 |
|
|
| 132. |
US Centers for Disease Control HIV/AIDS Surveillance Report
Year-end editions 1997, 1996, 1995, 1994, 1993 (AIDS indicator
conditions reported by age group, US) |
|
|
| 133. |
Interview with Christine Maggiore September 1997 |
|
|
| 134. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end 1998; 9(2) Calculations: David Crowe, Alberta Reappraising
AIDS Society; US Centers for Disease Control 1998 HIV/AIDS
Surveillance Report Year-end 1997 p25 Figure 6 |
|
|
| 135. |
Gallo R 1984 Science 224; Piatak M 1993 Science 259; Ho D 1991 New
England Journal of Medicine 324:961; Shaw G 1991 New England Journal
of Medicine 324:954; Cooper 1992 Lancet 341:1099 |
|
|
| 136. |
Duesberg P 1996 Inventing the AIDS Virus Regnery Press, Washington
DC p174-180 |
|
|
| 137. |
Bialy H, Duesberg P March 1995 Letter to Nature. Source: AIDS:
Virus or Drug Induced? Duesberg P (editor) 1996 Kluwer Academic
Publishers, Netherlands |
|
|
| 138. |
Ho D, et al 1995 Rapid Turnover of Plasma Virions and CD4
Lymphocytes in HIV-1 Infection Nature 373:123-126; Wei X, et al 1995
Nature 373:117-122 |
|
|
| 139. |
Kary Mullis at HEAL Los Angeles, October 25 1995 |
|
|
| 140. |
Philpott P, Johnson C 1996 Viral Load of Crap Reappraising AIDS
Vol 4:10 p2 |
|
|
| 141. |
Johnson C Viral Load and the PCR Continuum Vol 4:4 November/
December 1996 |
|
|
| 142. |
CDC faxback document #320320 sent in reply to an inquiry by
Christine Johnson |
|
|
| 143. |
Roche Amplicor PCR Diagnostics HIV-1 Monitor test kit pamphlet |
|
|
| 144. |
Defer C, et al 1992 Multicenter Quality Control of PCR Detection
of HIV DNA AIDS 6:659-663; Bush, et al 1992, Journal of AIDS 5:872;
Gerberding J 1994 Incidence and Prevalence of HIV, Hepatitis B, and
CMV Among Health Care Personnel at Risk for Blood Exposure Journal
of Infectious Disease 170:1410-1417; de Mendoza, et al 1998 False
Positive for HIV Using Commercial Viral Load Quantification Assays
AIDS 12:2076-2077; Rich J, et al 1999 Misdiagnosis of HIV Infection
by HIV-1 Plasma Viral Load Testing: A Case Series, Annals of
Internal Medicine 130:37-39 |
|
|
| 145. |
Schwartz D, et al 1997 Extensive Evaluation of a Seronegative
Participant in an HIV-1 Vaccine Trial as a Result of False-Positive
PCR, Lancet Vol 350 No 9073 p256 |
|
|
| 146. |
Rasnick D 1997 Kinetics Analysis of Consecutive HIV Proteolytic
Cleavages of the Gag-Pol Polyprotein Journal of Biological Chemistry
March 7 p6348-6353 |
|
|
| 147. |
Piatak M, et al 1993 Science 259:1749-53 |
|
|
| 148. |
Roderer M 1998 Getting to the HAART of T Cell Dynamics Nature
Medicine Vol 4:2 p145-146; Levy J 1996 AIDS Surrogate Markers: Is
There Truth in Numbers? JAMA Vol 276 p161-162 |
|
|
| 149. |
Levy J 1996 AIDS Surrogate Markers: Is There Truth in Numbers?
JAMA Vol 276 p161-162 |
|
|
| 150. |
Philpott P, Johnson C 1996 Viral Load of Crap Reappraising AIDS
Vol 4:10 p2 |
|
|
| 151. |
Papadopulos-Eleopulos E, et al 1988 Reappraisal of AIDS: Is the
Oxidation Induced by the Risk Factors the Primary Cause? Medical
Hypothesis 25:151-162 |
|
|
| 152. |
Papadopulos-Eleopulos E, et al 1993 Is A Positive Western Blot
Proof of HIV Infection? Bio/Technology 11:696-707;
Papadopulos-Eleopulos E, et al 1996 The Isolation of HIV: Has it
Really Been Achieved? Continuum Vol 4:3 Supplement p1-24; Turner V
1996 Do HIV Antibody Tests Prove HIV Infection? Continuum 1996 Vol
3:5 p8-11; Papadopulos-Eleopulos E, Stewart G, et al 1997 HIV
Antibodies: Further Questions and a Plea for Clarification Current
Medical Research and Opinion 13:627-634 |
|
|
| 153. |
Philpott P 1997 The Isolation Question Reappraising AIDS Vol 5:6
June/July/August |
|
|
| 154. |
Gallo R 1984 Science 224:497-508; Piatak M 1993 Science
259:1749-1754; Piatak M 1993 Lancet 341:1099; Daar, et al 1991 New
England Journal of Medicine 324[14]:961-964; Clark, et al 1991 New
England Journal of Medicine 324:954-960; Cooper, et al 1992 Lancet
340:1257-1258 |
|
|
| 155. |
Nature Magazine May 26 1994 |
|
|
| 156. |
Morning Report Los Angeles Times May 16 1996 F-2 |
|
|
| 157. |
Project Inform letter to Dr. Bruce Alberts, President of the
National Academy of Sciences, July 31 1997: Endorsements are for
signers as of August 20 1997 |
|
|
| 158. |
Letter to Christine Maggiore from Ric Parish, PLUS Programs
Manager, May 30 1997 |
|
|
| 159. |
Anderson MK 1997 Sick of It All The Valley Advocate January 15
1998 |
|
|
| 160. |
Farber C 1995 AIDS Inc.: Observations of an AIDS Dissident
Provincetown Positive April/May Issue p14-18 |
|
|
| 161. |
Garrett L The Virus at the End of The World Esquire magazine March
1999 |
|
|
| 162. |
A&U America's AIDS Magazine June 1999 Issue 56 |
|
|
| 163. |
Duesberg P 1987 Retroviruses as Carcinogens and Pathogens:
Expectations and Reality Cancer Research 47:1199-1220 |
|
|
| 164. |
Interview with Christine Maggiore August 25 1999 |
|
|
| 165. |
Eichenwald K, Kolata G Drug Trials Hide Conflicts for Doctors New
York Times May 16 1999 |
|
|
| 166. |
Smith M, Sticking Point: AIDS Vaccine Designed by Don Francis in
Final Testing San Francisco Weekly July 14 1999 |
|
|
| 167. |
CNN Website Massive Trial of AIDS Vaccine to Begin in Thailand
February 10 1999 8:27 pm EST |
|
|
| 168. |
Dissecting Room Lancet Vol 353 May 15 1999 p1719 |
|
|
| 169. |
McGinley L Price of Success: Powerful Treatments Create Growing
Rift Among AIDS Groups Wall Street Journal December 20 1996 |
|
|
| 170. |
Drug Money Counter Punch magazine July 1 1998 |
|
|
| 171. |
Farber C 1995 AIDS Inc.: Observations of an AIDS Dissident
Provincetown Positive April/May Issue p14-18 |
|
|
| 172. |
US Centers for Disease Control HIV/AIDS Surveillance Report
Year-end editions through 1998 |
|
|
| 173. |
WHO website http://hivinsite.ucsf.edu/social/un/2098.3ce6.html
Ratios of estimated AIDS cases/reported AIDS cases for African
countries with highest estimated AIDS cases: Angola 22/1; Congo
13/1; Ethiopia 55/1; Kenya 9/1; Madagascar 69/1; Mozambique 48/1;
Nigeria 35/1; South Africa 33/1; Uganda 37/1; Zimbabwe 10/1. For all
African countries (with available data) combined, the ratio of
estimated AIDS cases to reported AIDS cases is 16/1 |
|
|
| 174. |
CDC national AIDS advertising campaign, October 1987: 38 TV
commercials, 8 radio spots, 6 print ads |
|
|
| 175. |
Bennett A, Sharpe A Health Hazard: AIDS Fight Skewed by Federal
Campaign Exaggerating Risks Wall Street Journal May 1996 p1 |
|
|
| 176. |
Philpott P CDC Releases Data for 1995: What HIV/AIDS Epidemic?
Reappraising AIDS Vol 4:7 July 1996 |
|
|
| 177. |
US Centers for Disease Control HIV/AIDS Surveillance Report
Year-end editions 1993 through 1998 with one exception: AIDS in
teenage boys rose from 238 in 1994 to 245 in 1995 |
|
|
| 178. |
Laboratory Centre for Disease Control, Health Canada, 1998 HIV and
AIDS in Canada: Surveillance Report to December 31 1997 p1 |
|
|
| 179. |
Until There's a Cure advertisement www.until.org |
|
|
| 180. |
Interview with Patty Dwyer from Until There's A Cure September 3,
1999 (800) 888-UNTIL |
|
|
| 181. |
WHO website http://hivinsite.ucsf.edu/social/un/2098.3ce6.html
Ratios of estimated AIDS cases/reported AIDS cases for African
countries with highest estimated AIDS cases: Angola 22/1; Congo
13/1; Ethiopia 55/1; Kenya 9/1; Madagascar 69/1; Mozambique 48/1;
Nigeria 35/1; South Africa 33/1; Uganda 37/1; Zimbabwe 10/1. For all
African countries (with available data) combined, the ratio of
estimated AIDS cases to reported AIDS cases is 16/1 |
|
|
| 182. |
China Says HIV Cases Estimated at 400,000 April 1 1999 4:25 am EST
Reuters, Bejing |
|
|
| 183. |
Merck Manual 1899 first edition |
|
|
| 184. |
Mendelsohn R 1984 How To Raise a Healthy Child In Spite of Your
Doctor Ballentine Books, New York p13-15 |
|
|
| 185. |
The American Medical Association Encyclopedia of Medicine Random
House, New York p359; Mendelsohn R 1979 Confessions of a Medical
Heretic Contemporary Publishing Company, Chicago p28-29 |
|
|
| 186. |
The American Medical Association Encyclopedia of Medicine 1989
Random House, New York p 977 |
|
|
| 187. |
Kono R 1975 The SMON Virus Theory Lancet ii:370-371; Shigematsu H,
et al 1975 Epidemiological Approach to SMON Japanese Journal of
Medicine, Science and Biology, 28 Supplement 23-33; Soda T 1980 Drug
Induced Sufferings: Medical, Pharmaceutical and Legal Aspects
Excerpta Medica: Amersterdam |
|
|
| 188. |
Marshall B Why Doctors Aren't Curing Ulcers Fortune Magazine June
9 1997 |
|
|
| 189. |
Haney D Doctors Slow to Attack Bug Behind Ulcers Los Angeles Times
(API) February 11 1996 |
|
|
| 190. |
Marshall B Why Doctors Aren't Curing Ulcers Fortune Magazine June
9 1997 |
|
|
| 191. |
NIAID and NIH Report 1996 The Relationship Between HIV and AIDS p3 |
|
|
| 192. |
Giraldo R 1997 AIDS and Stressors Fundacion Arte y Cincia,
Medellin; Root-Bernstein R 1993 Rethinking AIDS The Free Press, New
York; Al Bayati A 1999 Get All the Facts: HIV Does Not Cause AIDS
Toxi-Health, Dixon, CA |
|
|
| 193. |
Root-Bernstein R 1993 Rethinking AIDS The Free Press, New York
p220-280; Brody S 1997 Sex at Risk Transaction Publishers, New
Brunswick; Plumley P 1995 Condomania: Common Sense or Nonsense? HEAL
Bulletin, HEAL New York |
|
|
| 194. |
Willner R 1994 Deadly Deception p30 Peltec Publishing; The Merck
Manual 1992 Immuno-deficiency Diseases p303 Table 19-1 Merck
Research Laboratories, Rahway; Fauci A, et al 1998 Principles of
Internal Medicine, Edition 14 McGraw Hill, New York |
|
|
| 195. |
Chandra R 1983 Nutrition, Immunity and Infection Lancet i:688-69.
Source: AIDS and Stressors; Merck Manual 1992 Immunodeficiency
Diseases p317-318, Immunodeficiency and Malnutrition Merck Research
Laboratories, Rahway; Chandra R 1975 Fetal Malnutrition and
Postnatal Immunocompetence American Journal of Dis Chil 125:450-455.
Source: AIDS and Stressors |
|
|
| 196. |
Merck Manual 1992 Immunodeficiency Diseases, p304 Table 19-2
Immunosuppressive Agents Merck Research Laboratories, Rahway; Heyer
A 1983 Introduction to Nutrition Keats Publishing, New Canaan p2-12;
Owen B 1995 You Don't Have to Die Sick Adrenal Exhaustion p43-46
Health Hope Publishing House, Cannon Beach |
|
|
| 197. |
The American Medical Association Encyclopedia of Medicine 1989
Random House, New York p258 |
|
|
| 198. |
Niwa Y, Yokoyama M 1981 Effect of Glucocorti-costeroid Therapy on
the Immune System of Patients with Nonimmunologically Mediated
Dermatose J Clin Lab Immunol 6(2):147-155; Parrillo J, Fauci A 1978
Mechanisms of Corticosteroid Action on Lymphocyte Subpopulations of
Effector Cells Mediating Cellular Toxicity in Man Clin Exp Immunol
31:116-125; Fauci A. Dale D, Balow J 1976 Glucocorticosteroid
Therapy: Mechanisms of Action and Clinical Considerations Annals of
Internal Medicine 84:304-15; Leung F, Fam A, Osoba D 1981 Kaposi's
Sarcoma Complicating Corticosteroid Therapy for Temporal Arteritis
The American Journal of Medicine 71(2):320-322 |
|
|
| 199. |
Merck Manual 1992 Anti-Infective Drugs: Sulfonamides p46-48 Merck
Research Laboratories, Rahway; Drugs Facts and Comparisons 1999
Facts and Comparisons Publishing, St. Louis (800) 223-0554 |
|
|
| 200. |
Duesberg P 1996 Inventing The AIDS Virus Regnery Publishing,
Washington DC p300 |
|
|
| 201. |
Merck Manual 1992 Anti-Infective Drugs: Sulfonamides p46-48 Merck
Research Laboratories, Rahway; Drugs Facts and Comparisons 1999
Facts and Comparisons Publishing, St. Louis (800) 223-0554 |
|
|
| 202. |
Bull Mem Soc Med Hopitaux de Paris, 3rd Ser 1909, 28:958-996;
Pharmacology Ther 1992 55: 201-207 |
|
|
| 203. |
Immune System Toxins Rachel's Environment and Health Weekly #536
March 6 1997; Statement on Immune Toxins #544 May 1 1997
Environmental Research Foundation, Annapolis |
|
|
| 204. |
Hebert C, Brecher M, et al Fewer Blood Transfusions Save Lives New
England Journal of Medicine February 1999; United Press
International, February 10 1999; Ward, et al 1989 The Natural
History of Transfusion Associated Infection With HIV New England
Journal of Medicine 321:947-952 |
|
|
| 205. |
Benson H 1997 The Nocebo Effect: History and Physiology Preventive
Medicine 26:612-615; Binik Y 1985 Psychosocial Predictors of Sudden
Death: A Review and Critique Social Science Medicine 20(7):667-80;
Cecchi R 1984 Stress: Prodrome to Immune Deficiency Annals of the
New York Academy of Sciences 437:286-289; Cohen S 1988 Voodoo Death,
the Stress Response, and AIDS Advanced Biochem Psychopharmacology
44:95-109; Golden K Voodoo in Africa and the United States December
1977 American Journal of Psychiatry 134 (12):1425-1427; Uno H, et al
1989 Hippocampal Damage Associated with Prolonged and Fatal Stress
in Primates Journal of Neuroscience 9(5):1705-1711; Milton G
Self-Willed Death or the Bone Pointing Syndrome June 23 1973 Lancet
1:1435-1436 |
|
|
| 206. |
Guyton A, Hall J 1996 Textbook of Medical Physiology Sanders, New
York p964-965 |
|
|
| 207. |
Cohan J Legally Speaking, Mason v Jacobs 4Front Magazine April 30
1997 |
|
|
| 208. |
Cannon W 1957 Voodoo Death Psychosomatic Medicine 19:182-190
(reprinted from American Anthropologist 44:1942); Campinha-Bacote J
1992 Voodoo Illness Perspectives in Psychiatric Care 28(1):11-17 |
|
|
| 209. |
The American Medical Association Encyclopedia of Medicine 1989
Random House, New York p798 |
|
|
| 210. |
Reuters News Service report, May 14 1998 on Canadian Amiodarone
Myocardial Infarction Arrhythmia Trial (CAMIAT), University of
Toronto, Canada |
|
|
| 211. |
Giraldo R 1997 AIDS and Stressors Fundacion Arte y Cincia,
Medellin; Root-Bernstein R 1993 Rethinking AIDS The Free Press, New
York; Al Bayati A 1999 Get All the Facts: HIV Does Not Cause AIDS
Toxi-Health, Dixon, CA |
|
|
| 212. |
Jagge, et al 1983 Annals of Internal Medicine 99:145-151 |
|
|
| 213. |
Osterloh J, et al 1984 Butyl Nitrite Transformation Invitro Anal
Toxicology 8:164-169; Haverkos H, et al 1985 Disease Manifestation
Among Homosexual Men with AIDS Sexually Transmitted Diseases
12:203-208; Root-Bernstein R 1990 Do We Know the Cause(s) of AIDS?
Pesp Biol Med 33:480-500 |
|
|
| 214. |
Krieger L Kaposi's Sarcoma, AIDS Link Questioned, San Francisco
Examiner June 5 1992 pA-1,A-17; US Centers for Disease Control
HIV/AIDS Surveillance Report Year-end reports 1993-1998 |
|
|
| 215. |
Marmor, Lancet May 15 1982 (100%); Jaffe, Annals of Internal
Medicine 1983 (96%); Harverkos, STD Oct/Nov 1985 (97%); Kaslow,
Journal of the American Medical Association 261:23 1989 (96%)
Archibald, Epidemiology 3:203 (100%); Duesberg, Genetica, February
1995 (93%) |
|
|
| 216. |
Yardley J, et al 1980 Immunologic Status in Patients with
Giardiasis, Gastroenterology 78: 421-422; Jaffe, et al 1983 Annals
of Internal Medicine 99:145-151 |
|
|
| 217. |
Bozzette S, et al 1990 A Controlled Trial of Early Adjunctive
Treatment with Corticosteroids for PCP Pneumonia in AIDS New England
Journal of Medicine 323 (21):145-7; Traltner A, et al 1993 The
Appearance of Kaposi's Sarcoma During Corticosteroid Therapy Cancer
72 (5):1779-1783 |
|
|
| 218. |
Average of two random issues of Edge magazine and Frontiers Gay
Biweekly magazine less classified, phone sex, theater and cinema
advertisements |
|
|
| 219. |
Merck Manual 1992 16th edition p55, Merck Research Laboratories;
Glaxo-Wellcome information sheet accompanying Zidovudine |
|
|
| 220. |
Ascher M, et al 1993 Does Drug Use Cause AIDS? Nature 362:103-104;
Schecter M, et al 1993 HIV-1 and the Aetiology of AIDS Lancet
341:658-659; Duesberg P 1993 Can Epidemiology Determine Whether
Drugs or HIV Cause AIDS? AIDS Forshung 12:627-635 |
|
|
| 221. |
Brody, S 1997 Sex at Risk Transaction Publishers, New Brunswick;
80%: Potterat et al 1987 JAMA 256 p 12; 65%: Renzullo et al 1990
JAIDS 3, p266-271; 83%-90%: Committee on AIDS Research and the
Behavioral, Social, and Statistical Sciences 1989; 69%: Chicago Dept
of Public Health, Journal of AIDS 1997; 99.4%: NYC Dept of Health,
American Journal of Epidemiology 137:2 |
|
|
| 222. |
Duesberg P, Rasnick D 1998 The AIDS Dilemma: Drug Diseases Based
on a Passenger Virus, Genetica 104: p109 Table 7 |
|
|
| 1c. |
Achard G, Bernard H, et al 1909 Action de la Morphine sur les
Proprietes Leucocytaires; Leucodiagnostic du Morphinisme Bulletin et
Memoires de la Societe Medicale des Hopitaux de Paris 28, 3rd
Series:958-966; Terry C, Pellens M 1928 The Opium Problem Bureau of
Social Hygiene of New York; Briggs J, McKerron C, et al 1967 Severe
Systemic Infection Complicating "Mainline" Heroin
Addiction Lancet ii:1227-1231; Sapira J 1968 The Narcotic Addict as
a Medical Patient Am J Med 45:555-558; Harris P, Garret R 1972
Susceptibility of Addicts to Infection and Neoplasia New Engl J Med
287:310; Geller S, Stimmel B 1973 Diagnostic Confusion from
Lymphatic Lesions in Heroin Addicts Ann Intern Med 78:703-705;
Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J
Nursing 73:2105-2109; Brown S, Stimmel B, et al 1974 Immunologic
Dysfunction in Heroin Addicts Arch Intern Med 134:1001-1006; Louria
D 1974 Infectious Complications of Nonalcoholic Drug Abuse Annu Rev
Med 25:219-231; McDonough R, Madden J, et al 1980 Alteration of T
and Null Lymphocyte Frequencies in the Peripheral Blood of Human
Opiate Addicts: In Vivo Evidence of Opiate Receptor Sites on T
Lymphocytes J Immunol 125:2539-2543; Gottlieb M, Schanker H, et al
1981 Pneumocystis PneumoniaLos Angeles Morbidity and Mortality
Weekly Reports 30:250-252; Marmor M, Friedman-Kien A, et al 1982
Risk Factors for Kaposi's Sarcoma in Homosexual Men Lancet
i:1083-1087; Jaffe H, Choi K, et al 1983 National Case-Control Study
of Kaposi's Sarcoma and Pneumocystis Carinii Pneumonia in Homosexual
Men: Part 1, Epidemiological Results Ann Intern Med 99:145-151;
Tubaro E, Borelli G, et al 1983 Effect of Morphine on Resistance to
Infection J Infect Dis 148:656-666; Layon J, Idris A, et al 1984
Altered T Lymphocyte Subsets in Hospitalized Intravenous Drug
Abusers Arch Intern Med 144:1376-1380; Newell G, Mansell P, et al
1985a Volatile Nitrites: Use and Adverse Effects Related to the
Current Epidemic of Acquired Immune Deficiency Syndrome Am J Med
78:811-816; Newell G, Mansell P, et al 1985b Risk Factor Analysis
Among Men Referred for Possible Acquired Immune Deficiency Syndrome
Preventive Med 14:81-91; Culver K, Ammann A, et al 1987 Lymphocyte
Abnormalities in Infants Born to Drug-Abusing Mothers J Pediatr
111:230-235; Donahoe R, Bueso-Ramos C, et al 1987 Mechanistic
Implications of the Findings that Opiates and Other Drugs of Abuse
Moderate T-cell Surface Receptors and Antigenic Markers Ann N.Y.
Acad Sci 496:711-721; Bureau of Justice Statistics 1988 Special
ReportDrug Law Violators, 1980-1986 US Department of Justice,
Washington DC; Haverkos H, Dougherty J (eds) 1988b Health Hazards of
Nitrite Inhalants US Department of Health and Human Services,
Washington DC; Selwyn P, Feingold A, et al 1988 Increased Risk of
Bacterial Pneumonia in HIV-Infected Intravenous Drug Users without
AIDS AIDS 2:267-272; Novick O, Ochshorn M, et al 1989 Natural Killer
Cell Activity and Lymphocyte Subsets in Parenteral Heroin Abusers
and Long-Term Methadone Maintenance Patients The Journal of
Pharmacology and Experimental Therapeutics 250:606-610; Mientjes G,
Miedema F, et al 1991 Frequent Injecting Impairs Lymphocyte
Reactivity in HIV-Positive and HIV-Negative Drug Users AIDS 5:35-41;
Pillai R, Nair B, et al 1991 AIDS, Drugs of Abuse and the Immune
System: A Complex Immunotoxicological Network Arch Toxicol
65:609-617; Larrat P, Zierler S 1993 Entangled Epidemics: Cocaine
Use and HIV Disease J Psychoactive Drugs 25:207-221; Mientjes G, van
Ameijden E, et al 1993 Clinical Symptoms Associated with
Seroconversion for HIV-1 among Misusers of Intravenous Drugs:
Comparison with Homosexual Seroconverters and Infected and
Non-Infected Intravenous Drug Misusers Br. Med. J. 306:371-373;
Sadownick D 1994 Kneeling at the Crystal Cathedral Genre
December/January 1994 p40-45, 86-90; Ratajczak H, Thomas P, et al
1995 Local Versus Systemic Immunotoxicity of Isobutyl Nitrite
Following Subchronic Inhalation Exposure of Female B6C3F1 Mice
Fundamental and Applied Technology 27:177-184; Brettle R 1996
Clinical Features of Drug Use and Drug Use Related to HIV Int J STD
& AIDS 7:151-165 |
|
|
| 2c. |
Jaffe H, Choi K, et al 1983 National Case-Control Study of
Kaposi's Sarcoma and Pneumocystis Carinii Pneumonia in Homosexual
Men: Part 1, Epidemiological Results Ann Intern Med 99:145-151;
Newell G, Adamas S, et al 1984 Toxicity, Immunosuppressive Effects
and Carcinogenic Potential of Volatile Nitrites: Possible
Relationship to Kaposi's Sarcoma Pharmacotherapy 4:284-291; Haverkos
H, Pinsky P, et al 1985 Disease Manifestation Among Homosexual Men
with Acquired Immunodeficiency Syndrome: A Possible Role of Nitrites
in Kaposi's Sarcoma J Sex Trans Dis 12:203-208; Haverkos H, Kaposi's
Sarcoma and Nitrite Inhalants In: Psychological, Neuropsychiatric
and Substance Abuse Aspects of AIDS by Bridge T, Heather H, Johnson
M (eds) Raven Press, New York p165-172; Haverkos H, Dougherty J
1988a Health Hazards of Nitrite Inhalants Am J Med 84:479-482;
Archer C, Spittle M, et al 1989 Kaposi's Sarcoma in a Homosexual10
Years On Clin Exper Dermatol 14:233-236; Friedman-Kien A, Saltzman
B, et al 1990 Kaposi's Sarcoma in HIV-Negative Homosexual Men Lancet
335:168-169; Marquart K, Engst R, et al 1991 An 8-Year History of
Kaposi's Sarcoma in an HIV-Negative Bisexual Man AIDS 5:346-348;
Safai B, Peralta H, et al 1991 Kaposi's Sarcoma among HIV-Negative
High Risk Populations VII International Conference on AIDS,
Florence, Italy |
|
|
| 3c. |
Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J
Nursing 73:2105-2109; Stoneburner R, Des Jarlais D, et al 1988 A
Larger Spectrum of Severe HIV-1-Related Disease in Intravenous Drug
Users in New York City Science 242:916-919; Rogers M, Ou C, et al
1989 Use of the Polymerase Chain Reaction for Early Detection of the
Proviral Sequences of Human Immunodeficiency Virus in Infants Born
to Seropositive Mothers N Engl J Med 320:1649-1654 |
|
|
| 4c. |
Gottlieb M, Schanker H, et al 1981 Pneumocystis PneumoniaLos
Angeles Morbidity and Mortality Weekly Reports 30:250-252; Jaffe H,
Choi K, et al 1983 National Case-Control Study of Kaposi's Sarcoma
and Pneumocystis Carinii Pneumonia in Homosexual Men: Part 1,
Epidemiological Results Ann Intern Med 99:145-151; Mathur-Wagh U,
Enlow R, et al 1984 Longitudinal Study of Persistent Generalized
Lymphadenopathy in Homosexual Men: Relation to Acquired
Immunodeficiency Syndrome Lancet i:1033-1038; Mathur-Wagh U, Mildvan
D, et al 1985 Follow-Up of 41/2 Years on Homosexual Men with
Generalized Lymphadenopathy N Engl J Med 313:1542-1543; Selwyn P,
Feingold A, et al 1988 Increased Risk of Bacterial Pneumonia in
HIV-Infected Intravenous Drug Users without AIDS AIDS 2:267- |
|
|
| 5c. |
Geller S, Stimmel B 1973 Diagnostic Confusion from Lymphatic
Lesions in Heroin Addicts Ann Intern Med 78:703-705; Pillari G,
Narus J 1973 Physical Effects of Heroin Addiction Am J Nursing
73:2105-2109; Espinoza P, Bouchard I, et al 1987 High Prevalence of
Infection by Hepatitis B Virus and HIV in Incarcerated French Drug
Addicts Gastroenterologie Clinique et Biologique 11:288-292; Des
Jarlais D, Friedman S, et al 1988 Risk Reduction of the Acquired
Immune Deficiency Syndrome among Intravenous Drug Users In: AIDS and
IV Drug Abusers: Current Perspectives by Galea R, Lewis B, Baker L (eds)
National Health Publishing, Owings Mills, MD p97-109; Brettle R 1996
Clinical Features of Drug Use and Drug Use Related to HIV Int J STD
& AIDS 7:151-165 |
|
|
| 6c. |
Firooznia H, Seliger G, et al 1973 Disseminated Extrapulmonary
Tuberculosis in Association with Heroin Addiction Radiology
109:291-296; Courtwright D 1982 Dark Paradise: Opiate Addiction in
America Before 1940 Harvard University Press, Cambridge, MA; Layon
J, Idris A, et al 1984 Altered T Lymphocyte Subsets in Hospitalized
Intravenous Drug Abusers Arch Intern Med 144:1376-1380; Stoneburner
R, Des Jarlais D, et al 1988 A Larger Spectrum of Severe
HIV-1-Related Disease in Intravenous Drug Users in New York City
Science 242:916-919; Braun M, Truman B, et al 1989 Increasing
Incidence of Tuberculosis in a Prison Inmate Population, Associated
with HIV Infection J Am Med Assoc 261:393-397; Brudney K, Dobkin J
1991 Resurgent Tuberculosis in New York City Am Rev Respir Dis
144:744-749; Hayes T, Altman R, et al 1994 HIV-Related Deaths from
Selected Infectious Diseases among Persons without AIDS in New
Jersey Journal of Acquired Immune Deficiency Syndromes 7:1074-1078 |
|
|
| 7c. |
Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J
Nursing 73:2105-2109; Des Jarlais D, Friedman S, et al1988 Risk
Reduction of the Acquired Immune Deficiency Syndrome among
Intravenous Drug Users In: AIDS and IV Drug Abusers: Current
Perspectives by Galea R, Lewis B, Baker L (eds) National Health
Publishing, Owings Mills, MD p97-109; Brettle R 1996 Clinical
Features of Drug Use and Drug Use Related to HIV Int J STD &
AIDS 7:151-165; Bergling T 1997 All Methed Up: Doing Crystal Meth
Will Lift You Up Until You Break Genre 53:October p45-47,88; McEvoy
A, Kitchen N, et al 1998 Intracerebral Haemorrhage Caused by Drug
Abuse Lancet 351:1029 |
|
|
| 8c. |
Stoneburner R, Des Jarlais D, et al 1988 A Larger Spectrum of
Severe HIV-1-Related Disease in Intravenous Drug Users in New York
City Science 242:916-919; Koch T July 30 1990 Uninfected Children of
HIV-Infected Mothers May Still Suffer Nervous Problems CDC AIDS
Weekly p9; Aylward E, Butz A, et al 1992 Cognitive and Motor
Development in Infants at Risk for Human Immunodeficiency Virus Am J
Dis Child 146:218-222; Larrat P, Zierler S 1993 Entangled Epidemics:
Cocaine Use and HIV Disease J Psychoactive Drugs 25:207-221; Hayes
T, Altman R, et al 1994 HIV-Related Deaths from Selected Infectious
Diseases among Persons without AIDS in New Jersey Journal of
Acquired Immune Deficiency Syndromes 7:1074-1078; Brettle R 1996
Clinical Features of Drug Use and Drug Use Related to HIV Int J STD
& AIDS 7:151-165; McEvoy A, Kitchen N, et al 1998 Intracerebral
Haemorrhage Caused by Drug Abuse Lancet 351:1029 |
|
|
| 9c. |
Des Jarlais D, Friedman S, et al 1988 Risk Reduction of the
Acquired Immune Deficiency Syndrome among Intravenous Drug Users In:
AIDS and IV Drug Abusers: Current Perspectives by Galea R, Lewis B,
Baker L (eds) National Health Publishing, Owings Mills, MD p97-109;
Muñoz A, Vlahov D, et al 1992 Prognostic Indicators for
Development of AIDS among Intravenous Drug Users J Acquir Immune
Defic Syndr 5:694-700; Brettle R 1996 Clinical Features of Drug Use
and Drug Use Related to HIV Int J STD & AIDS 7:151-165 |
|
|
| 10c. |
Des Jarlais D, Friedman S, et al 1988 Risk Reduction of the
Acquired Immune Deficiency Syndrome among Intravenous Drug Users In:
AIDS and IV Drug Abusers: Current Perspectives by Galea R, Lewis B,
Baker L (eds) National Health Publishing, Owings Mills, MD p97-109;
Ettinger N, Albin R 1989 A Review of the Respiratory Effects of
Smoking Cocaine Am J Med 87:664-668; Brettle R 1996 Clinical
Features of Drug Use and Drug Use Related to HIV Int J STD &
AIDS 7:151-165 |
|
|
| 11c. |
Savona S, Nardi M, et al 1985 Thrombocytopenic Purpura in
Narcotics Addicts Ann Intern Med 102:737-741 |
|
|
| 12c. |
Fricker H, Segal S 1978 Narcotic Addiction, Pregnancy, and the
Newborn Am J Dis Child 132:360-366; Lifschitz M, Wilson G, et al
1983 Fetal and Postnatal growth of Children Born to
Narcotic-Dependent Women J Pediatr 102:686-691; Alroomi L, Davidson
J, et al 1988 Maternal Narcotic Abuse and the Newborn Arch Dis Child
63:81-83; Rogers M, Ou C, et al 1989 Use of the Polymerase Chain
Reaction for Early Detection of the Proviral Sequences of Human
Immunodeficiency Virus in Infants Born to Seropositive Mothers N
Engl J Med 320:1649-1654; Toufexis A May 13 1991 Innocent Victims
Time p56-60; Finnegan L, Mellot J, et al 1992 Perinatal Exposure to
Cocaine: Human Studies In: Cocaine: Pharmacology, Physiology and
Clinical Strategies by Lakoski J, Galloway M, White F (eds) CRC
Press, Boca Raton, FL p391-409; Larrat P, Zierler S 1993 Entangled
Epidemics: Cocaine Use and HIV Disease J Psychoactive Drugs
25:207-221 |
|
|
| 13c. |
Des Jarlais D, Friedman S, et al 1988 Risk Reduction of the
Acquired Immune Deficiency Syndrome among Intravenous Drug Users In:
AIDS and IV Drug Abusers: Current Perspectives by Galea R, Lewis B,
Baker L (eds) National Health Publishing, Owings Mills, MD p97-109;
Brettle R 1996 Clinical Features of Drug Use and Drug Use Related to
HIV Int J STD & AIDS 7:151-165 |
|
|
| 14c. |
Larrat P, Zierler S 1993 Entangled Epidemics: Cocaine Use and HIV
Disease J Psychoactive Drugs 25:207-221; Brettle R 1996 Clinical
Features of Drug Use and Drug Use Related to HIV Int J STD &
AIDS 7:151-165 |
|
|
| 15c. |
Wilson J, Kalasinsky K, et al 1996 Striatal Dopamine Nerve
Terminal Markers in Human, Chronic Methamphetamine Users Nature
Medicine 2:699-703 |
|
|
| 16c. |
Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J
Nursing 73:2105-2109 |
|
|
| 17c. |
Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J
Nursing 73:2105-2109; Brettle R 1996 Clinical Features of Drug Use
and Drug Use Related to HIV Int J STD & AIDS 7:151-165 |
|
|
| 18c. |
Dismukes W, Karchmer A, et al 1968 Viral Hepatitis Associated with
Illicit Parenteral Use of Drugs J Am Med Assoc 206:1048-1052;
Pillari G, Narus J 1973 Physical Effects of Heroin Addiction Am J
Nursing 73:2105-2109; Layon J, Idris A, et al 1984 Altered T
Lymphocyte Subsets in Hospitalized Intravenous Drug Abusers Arch
Intern Med 144:1376-1380 |
|
|
| 19c. |
Brettle R 1996 Clinical Features of Drug Use and Drug Use Related
to HIV Int J STD & AIDS 7:151-165 |
|
|
| 20c. |
Layon J, Idris A, et al 1984 Altered T Lymphocyte Subsets in
Hospitalized Intravenous Drug Abusers Arch Intern Med 144:1376-1380;
Stoneburner R, Des Jarlais D, et al 1988 A Larger Spectrum of Severe
HIV-1-Related Disease in Intravenous Drug Users in New York City
Science 242:916-919; Mientjes G, van Ameijden E, et al 1993 Clinical
Symptoms Associated with Seroconversion for HIV-1 among Misusers of
Intravenous Drugs: Comparison with Homosexual Seroconverters and
Infected and Non-Infected Intravenous Drug Misusers Br. Med. J.
306:371-373; Brettle R 1996 Clinical Features of Drug Use and Drug
Use Related to HIV Int J STD & AIDS 7:151-165 |
|
|
| 223. |
Indiana Hemophilia Foundation. Source: Duesberg P 1996 Inventing
the AIDS Virus Regnery Publishing, Washington DC p287-288 |
|
|
| 224. |
Blood Transfusions: Fewer Blood Transfusions Save Lives United
Press International February 10 1999; Hebert P, et al New England
Journal of Medicine February 11 1999 |
|
|
| 225. |
Brody, S 1997 Sex at Risk Transaction Publishers, New Brunswick;
80%: Potterat et al 1987 JAMA 256 p 12; 65%: Renzullo, et al 1990
JAIDS 3, p266-271; 83%-90%: Committee on AIDS Research and the
Behavioral, Social, and Statistical Sciences 1989; 69%: Chicago Dept
of Public Health, Journal of AIDS 1997; 99.4%: NYC Dept of Health,
American Journal of Epidemiology 137:2 |
|
|
| 226. |
Fumento M Washington Times June 8 1999 |
|
|
| 227. |
US Centers for Disease Control 1999 HIV/AIDS Surveillance Report
Year-end 1998 p14 Table 5 |
|
|
| 228. |
Altman L Outside of US and Europe HIV Transmission is Through
Heterosexual Contact New York Times November 2 1993 |
|
|
| 229. |
Biggar R, et al 1985 ELISA HTLV Retrovirus Antibody Reactivity
Associated With Malaria Lancet ii 520-543; Charmot G, Simon F 1990
HIV Infection and Malaria Revue Du Practien 40:2124; Bush, et al
Journal of AIDS 5:872 1992; Kashala O, et al 1994 Infection with
HIV-1 and Human T Cell Lymhotropic Viruses Among Leprosy Patients
and Contacts Journal of Infectious Diseases 169:292-304 |
|
|
| 230. |
Piatak M, et al 1993 Science 259:1749-53 |
|
|
| 231. |
World Health Organization annual conversions rates. Source:
Willner R Deadly Deception Peltec Publishing p39-41 |
|
|
| 232. |
Benthen B, et al Insights from the Tricontinental Seroconverter
Study AIDS June 18 1998 12:1039-1045; New England Journal of
Medicine 1995 332:209; Journal of Infectious Diseases 1996 173:60 |
|
|
| 233. |
Buchbinder S, et al 1994 Long Term HIV 1 Infection Without
Immunologic Progression AIDS 8:1123; Pantaleo G, et al 1995 Studies
in Subjects with Long-Term Non-Progressive HIV Infection New England
Journal of Medicine 332(4):209-216; Muñoz A, et al 1995
Long-Term Survivors of HIV-1 Infection Journal of AIDS and Human
Retrovirology April 15 8(5):496-505 |
|
|
| 234. |
Journal InterAM Medical Health Association 1992 1:1-8 |
|
|
| 235. |
Callen M Surviving AIDS Harper-Collins Publishing; Root-Bernstein
R Rethinking AIDS The Free Press, New York p361-363; Time Magazine
March 22 1993; Gregory S, Leonardo B 1992 They Conquered AIDS: True
Life Adventures; MacIntyre R, Mortal Men: Living with Asymptomatic
HIV University Press, Rutgers; Chaitow L, Strohecker J 1997 You
Don't Have to Die: Unraveling the AIDS Myth Future Medicine
Publishing |
|
|
| 236. |
Genetica 1996 AIDS: Virus or Drug Induced? p3-22; Ostrom N The T4
Myth New York Native May 2 1994 |
|
|
| 237. |
Bird A 1996 Non-HIV AIDS Journal of Antimicrobial Chemotherapy
37(B):171-183; Haynes S California State Department of Health
Services AIDS Study. Source: Farber C SPIN magazine May 1994 |
|
|
| 238. |
Mosley J Transfusion Safety Study Group Report presented at 1993
International AIDS conference. Source: Farber C SPIN magazine May
1994 |
|
|
| 239. |
Fleming T, De Mets D Surrogate End Points in Clinical Trials: Are
We Being Misled? Annals of Internal Medicine October 1 1996
125:605-613 |
|
|
| 240. |
Carney W, Rubin R, et al Analysis of T Lymphocyte Subsets in CMV
Mononucleosis June 1981 Journal of Immunology; Feeney C, Bryzman S,
et al October 1995 T-Lymphocyte Subsets in Acute Illness Critical
Care Medicine 23 (10):1680-1685 |
|
|
| 241. |
US Centers for Disease Control, 1998 Guidelines for the Use of
Antiretroviral Agents in HIV-Infected Adults and Adolescents |
|
|
| 242. |
Source for entire section: The American Association of Oriental
Medicine Understanding Oriental Medicine, Acupuncture and Herbology
Catasauqua, PA; Cassileth B PhD The Alternative Medicine Handbook WW
Norton & Co, New York; The Complete Guide to Alternative And
Conventional Treatments Time Life Books, Alexandria; Mortimore D The
Complete Illustrated Guide to Nutritional Healing, Element Press,
Boston; New Choices in Natural Healing, Rodale Press Inc., Emmaus;
Tips J PhD Your Liver...Your Lifeline: Detoxification and
Rejuvenation for the Whole Body Apple-A-Day Press, Austin; Jensen B
PhD DC Tissue Cleansing Through Bowel Management Bernard Jensen
International, Escondido |
|
|
| 243. |
POZ Magazine July 1992 |
|
|
| 244. |
Schwartz D, et al 1997 Extensive Evaluation of a Seronegative
Participant in an HIV-1 Vaccine Trial as a Result of False-Positive
PCR, Lancet Vol 350 No 9073 p256 |
|
|
| 245. |
Wall Street Journal May 1 1996 |
|
|
| 246. |
American Heritage Dictionary Second College Edition Houghton
Mittlin Company, Boston p492 |
|
|
| 247. |
Documentary film HIV=AIDS: Fact or Fraud Starvision Productions
Denver CO 1997; CNN Website Massive Trial of AIDS Vaccine to Begin
in Thailand February 10 1999 8:27 pm EST |
|
|
| 248. |
Altman L Inherited Factor May Play Role in Risk of AIDS New York
Times May 10 1987 |
|
|
| 272. |
Stoneburner R, Des Jarlais D, et al 1988 A Larger Spectrum of
Severe HIV-1-Related Disease in Intravenous Drug Users in New York
City Science 242:916-919; Ettinger N, Albin R 1989 A Review of the
Respiratory Effects of Smoking Cocaine Am J Med 87:664-668; Mientjes
G, van Ameijden E, et al 1993 Clinical Symptoms Associated with
Seroconversion for HIV-1 among Misusers of Intravenous Drugs:
Comparison with Homosexual Seroconverters and Infected and
Non-Infected Intravenous Drug Misusers Br. Med. J. 306:371-373;
Hayes T, Altman R, et al 1994 HIV-Related Deaths from Selected
Infectious Diseases among Persons without AIDS in New Jersey Journal
of Acquired Immune Deficiency Syndromes 7:1074-1078; Brettle R 1996
Clinical Features of Drug Use and Drug Use Related to HIV Int J STD
& AIDS 7:151-165 |
